NCT02247557View on ClinicalTrials.gov

Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Interstitial Cystitis
Interventions
DRUG

Liposome encapsulated BoNT-A

Liposome encapsulated BoNT-A ( mixed BOTOX 200U/10ml in Liposome 80mg/40ml) in single intravesical instillation

DRUG

BOTOX 200U in normal saline

BOTOX 200U in normal saline (BoNT-A/NS) 50ml in single intravesical instillation

DRUG

Normal saline

Normal saline (N/S) 50ml in single intravesical instillation

Trial Locations (1)

970

Buddhist Tzu Chi General Hospital, Hualien City

All Listed Sponsors
lead

Buddhist Tzu Chi General Hospital

OTHER

NCT02247557 - Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis | Biotech Hunter | Biotech Hunter